SOW
BMRN icon

State of Wyoming’s BioMarin Pharmaceuticals BMRN Stock Holding History

State of Wyoming’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Buy
+9,980
New +$547K 0.06% 323
2026
Q1 		– Sell
-3,380
Closed -$201K – 1820
2025
Q4 		$201K Sell
3,380
-6,606
-66% -$360K 0.02% 972
2025
Q3 		$541K Sell
9,986
-3,027
-23% -$173K 0.06% 276
2025
Q2 		$715K Buy
13,013
+7,212
+124% +$425K 0.09% 151
2025
Q1 		$410K Buy
5,801
+1,098
+23% +$73.9K 0.05% 341
2024
Q4 		$309K Buy
4,703
+3,984
+554% +$267K 0.04% 534
2024
Q3 		$50.5K Sell
719
-1,658
-70% -$139K 0.01% 1445
2024
Q2 		$196K Buy
2,377
+1,724
+264% +$144K 0.03% 572
2024
Q1 		$57K Buy
653
+319
+96% +$28.6K 0.01% 1258
2023
Q4 		$32.2K Sell
334
-3
-0.9% -$265 0.01% 1491
2023
Q3 		$29.8K Buy
+337
New +$30K 0.01% 1420
2023
Q1 		– Sell
-399
Closed -$41.3K – 1601
2022
Q4 		$41.3K Buy
+399
New +$37.5K 0.01% 1127
2022
Q3 		– Sell
-648
Closed -$54K – 1560
2022
Q2 		$54K Sell
648
-5,547
-90% -$442K 0.03% 879
2022
Q1 		$478K Buy
6,195
+270
+5% +$22.6K 0.24% 28
2021
Q4 		$523K Buy
5,925
+384
+7% +$31.7K 0.24% 27
2021
Q3 		$428K Sell
5,541
-1,088
-16% -$85.8K 0.28% 46
2021
Q2 		$553K Buy
6,629
+6,329
+2,110% +$502K 0.35% 37
2021
Q1 		$23K Buy
+300
New +$24.5K 0.04% 299

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State of Wyoming's BMRN Position: Q2 2026 in Review

State of Wyoming opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 9,980 shares worth $571K. The stake represents 0.06% of the portfolio and ranks #323 among its holdings. This is a return to the name: State of Wyoming previously reported a position in BMRN as recently as Q4 2025.

State of Wyoming first reported a position in BMRN in Q1 2021 and has held it in 18 quarters since. The position peaked at $715K in Q2 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • State of Wyoming held 9,980 shares of BioMarin Pharmaceuticals worth $571K as of Q2 2026.
  • BioMarin Pharmaceuticals was a new State of Wyoming position in Q2 2026.
  • BioMarin Pharmaceuticals made up 0.06% of State of Wyoming's portfolio in Q2 2026, its #323 holding.
  • State of Wyoming first reported a position in BioMarin Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • State of Wyoming's BioMarin Pharmaceuticals position peaked at $715K in Q2 2025.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.